- For the University
- For external organisations
- What’s on
- Contact us
We share knowledge and expertise with partners both inside and outside of the University.
We have been instrumental in the creation of two key ventures in the fields of drug discovery and agri-tech. Other partnerships include our work with Cambridge Judge Business School in the area of social enterprise and links within the NHS locally to promote innovation in medical technology.
Apollo Therapeutics is a novel collaborative venture created in 2016 in order to accelerate new drugs towards market. It combines the expertise of the world-leading UK universities of Cambridge, Imperial College London and University College London with global pharmaceutical companies AstraZeneca, GlaxoSmithKline and Johnson & Johnson Innovation.
Launched in 2018, the Ceres Agri-Tech Knowledge Exchange Partnership catalyses early stage technology transfer from the agri-tech cluster in the East of England in order to drive competitiveness and efficiency in this globally critical sector. Ceres supports commercialisation of agri-tech research and innovation by sharing knowledge and expertise through a partnership among the universities of Cambridge, East Anglia, Hertfordshire, Lincoln and Reading together with the John Innes Centre, NIAB and Rothamsted Research.
We work with Cambridge Social Ventures at Cambridge Judge Business School’s Centre for Social Innovation to support budding social entrepreneurs. Their 12-month social incubator helps social entrepreneurs find mentors, connect to the market, attract funding and develop a working business model. Through our partnership, projects driven by University members may apply for early stage investment in the form of our Social Pathfinder.
We work in close partnership with Cambridge University Hospitals, the NHS Foundation Trust and NHS Innovation Partner Health Enterprise East. Our office at the University’s School of Clinical Medicine gives us a base on the Addenbrooke’s site to assist in the development of innovative medical technology products and services in conjunction with NHS employees.